April 21, 2021
|
|
Redlands campus |
Marin campus |
All other campuses |
|
On-site worker new cases1 in last 7 days |
0 |
0 |
0 |
|
Telecommuter new cases1 in last 7 days |
0 |
0 |
0 |
|
Total cases since May 2020 |
59 (7.6%) |
1 (3.4%) |
3 (27%) |
[1] Laboratory confirmed positive cases.
|
|
Redlands campus |
Redlands local off-campus4 |
Marin campus |
|
New cases1 in last 7 days |
0 |
0 |
0 |
|
Total cases (Redlands from Jan. 2021; Marin from May 2020) |
13 (2.9%) |
29 |
0 |
|
Currently in isolation2 |
0 |
0 |
0 |
|
Currently in quarantine3 |
0 |
0 |
0 |
[1] Laboratory confirmed positive cases.
[2] Laboratory confirmed positive cases who are being kept away from others until deemed no longer a risk of spreading the disease.
[3] Students with known exposure to a positive case and/or those showing symptoms but not yet confirmed via laboratory results who are separated from others and restricted in their movements.
[4] Off-campus students living within the vicinity of the City of Redlands proper and who choose to report (they are not required to do so unless they have been on campus). To provide a sense of scope, 288 students informed the University that they would be living off-site, local to the Redlands campus.
San Bernardino County: Tier 3/orange (moderate); 1.9% testing positivity rate (7-day average)
Marin County: Tier 3/orange (moderate); 0.5% testing positivity rate (7-day average)
This week, the 25,000th shot was administered at the vaccination clinic on the University of Redlands main campus. The clinic, a partnership with Redlands Community Hospital, continues to serve San Bernardino residents 18 years or older. Register for an appointment or volunteer at the clinic through the U of R vaccination clinic website.
If you are experiencing any symptoms associated with COVID-19, please fill out the COVID-19 Symptoms, Exposure, or Positive Test Reporting Form, available on the UR Ready website. The Centers for Disease Control and Prevention lists the following symptoms as associated with COVID:
See also the January 25 memo for information on “What happens after a COVID-19 report is submitted.”
The U.S. State Department has “strongly recommended that U.S. citizens reconsider all travel abroad.” In a media statement issued on Monday, the agency said it will begin updating its travel advisories to better reflect the unprecedented risks of COVID-19. This will result in a significant increase in the number of countries at “Level 4: Do Not Travel” to approximately 80% of countries worldwide.
Claudia Wallis interviews heart drug researcher John H. Alexander, a cardiologist and senior researcher at the Duke Clinical Research Institute, who describes how the pandemic has spotlighted ways to make clinical trials easier on patients and better for science. Read Scientific American article “COVID Showed How Trials for New Drugs Could Be Faster and Better.”
Do you have an article to recommend to others or suggestions for this newsletter? Email urreadybrief@redlands.edu.
Additional information on the University’s COVID-19 response—including FAQs, videos, and past messages—is available at Redlands.edu/URready.
